Keywords
How to Cite
Abstract
This scientific review provides a comprehensive and up-to-date analysis on Future Perspectives in Immunomodulatory Therapies for Psoriasis. Given the complexity and variability of this dermatological condition, it becomes crucial to thoroughly examine the available therapeutic approaches for a more effective understanding of this clinical challenge. Psoriasis, with its diverse clinical presentations, demands a holistic evaluation of available therapies, ranging from IL-23 inhibitors to lifestyle interventions, offering a complete overview of the current landscape.
Not only does it highlight the diversity of available therapeutic approaches, but the review also emphasizes the crucial importance of personalization and early intervention. Recognizing the different manifestations of psoriasis and individual patient responses, the study underscores how therapeutic strategies tailored to the specific characteristics of each individual are essential to optimize outcomes. This personalization not only takes into account the uniqueness of each patient but also underscores the need for an integrative and multifaceted approach to psoriasis treatment.
By exploring the latest findings and developments in this field, this study goes beyond consolidating existing information, aiming to foster a critical reflection on current therapeutic practices in psoriasis. In doing so, it provides valuable insights for healthcare professionals, researchers, and patients, fostering a deeper understanding of therapeutic strategies and contributing to the ongoing improvement of the quality of life for individuals with psoriasis.
References
Bai, F., et al. (2019). Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Journal of Immunology Research, Volume 2019.
Buhas, M. C., et al. (2023). Transforming Psoriasis Care: Probiotics and Prebiotics as Novel Therapeutic Approaches. International Journal of Molecular Sciences, Volume 24, 11225.
Burden, A. D. (2023). Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis. Expert Review of Clinical Immunology, Volume 19, Issue 5, 473–481.
Guo, J., et al. (2023). Signaling pathways and targeted therapies for psoriasis. Signal Transduction and Targeted Therapy, Volume 8, 437.
Metko, D., Torres, T., & Vender, R. (2023). Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators? Journal of International Medical Research, Volume 51, Issue 6, 1–5.
Naik, P. P. (2022). Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Systematic Review. Dermatology, Volume 238, 886–896.
NÄSLUND-KOCH, C., et al. (2020). Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis. Therapeutics and Clinical Risk Management, Volume 16, 903–916.
Pinter, A., et al. (2021). Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients, Volume 13, 3015.
Reich, K., et al. (2019). Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. The Lancet. DOI: S0140-6736(19)31772-6.
Said, J. T., et al. (2022). Treatment of Immune Checkpoint Inhibitor-Mediated Psoriasis: A Systematic Review. J Am Acad Dermatol, Volume 87, Issue 2, 399–400.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Maria Luiza Sarmento dos Santos, Taíssa Louzada Sandrini , Carla Lavagnoli Reis, Vivia Cristina Pires Martins , Ana Flávia Prado de Oliveira , Marianna Costa de Niemeyer, Fabiana Rose Martins, Eduarda Drago Magnago , Fernanda Valentini Boscardin de Oliveira , Alicia Demuner Bonatti, Nicole Aquino Furtado, Giovanna Pauletti de Castro, Amanda Pinheiro Basto, Sarah Oliveira Benine